ARTICLE | Clinical News
Immupath: Filed IND to begin Phase III trials.
January 10, 1994 8:00 AM UTC
HemaCare Corp. (HEMA), Sherman Oaks, Calif. Product: Immupath, plasma-derived drug from asymptomatic HIV-positive donors Indication: Treat AIDS Status: Filed IND to begin Phase III trials in patients...